This site uses cookies to bring you the best experience. Find out more
Skip to main content
↑

News

Find Out The Latest

Keep in touch with exciting developments from The Oxford Science Park and its occupiers here.

Contact us on comms@oxfordsp.com if you would like to know more about any of these stories.

You can also follow us on X or LinkedIn  

Mace awarded contract to deliver The Daubeny Project at The Oxford Science Park

Mace awarded contract to deliver The Daubeny Project at The Oxford Science Park

22 Jul 2024

Mace has been awarded a £184 million contract to deliver the next expansion phase at The Oxford Science Park, The Daubeny Project. This landmark project will see the construction of three new state-of-the-art laboratory and office buildings, further cementing Oxford's position as a world-leading centre for scientific innovation. The expansion will add 400,500 sq ft of premium laboratory and office space to the park, addressing the critical... Read more

Moa harvests global deal for new herbicide

Moa harvests global deal for new herbicide

11 Jul 2024

Oxford, UK  8 July2024 – Agricultural biotech firm Moa Technology has signed a research and commercial partnership with Nufarm,a global agricultural innovator based in Melbourne, Australia. Moa has discovered several promising new classes of herbicide with its breakthrough innovation platform, which are currently in field trials in the US, UK, France and Spain. The deal provides Nufarm exclusive access to a new mode of action product in one... Read more

Ochre Bio enters into multi-year data licence agreement with GSK to further investigate the drivers of liver disease

Ochre Bio enters into multi-year data licence agreement with GSK to further investigate the drivers of liver disease

14 Jun 2024

We are delighted to announce that a Park occupier Ochre Bio has entered a multi-year data licence agreement with GSK to investigate the drivers of liver disease, a condition which can be fatal, killing 1 in 25 people worldwide. The partnership aims to prioritise and speed up the development of new treatments for liver conditions. Ochre Bio enters into a multi-year data licence agreement with GSK to further investigate the drivers of liver... Read more

Construction of The Daubeny Project has commenced

Construction of The Daubeny Project has commenced

11 Jun 2024

Construction has started on three new state-of-the-art laboratory and office buildings on The Oxford Science Park (TOSP), one of Europe's leading locations for science and technology companies. The Daubeny Project is a 450,000 sq ft commercial life science development, expected to complete in 2026, which provides significant grow-on space for the Park’s flourishing occupiers as well as new companies from the global life sciences... Read more

Pioneer Prof Sir John Bell appointed as President, Ellison Institute of Technology Oxford and Co-CEO of EIT Global

Pioneer Prof Sir John Bell appointed as President, Ellison Institute of Technology Oxford and Co-CEO of EIT Global

22 Feb 2024

The Ellison Institute of Technology (EIT) has today announced Prof Sir John Bell, Regius Professor of Medicine, University of Oxford, as the President of EIT Oxford. Prof Bell will also become Co-CEO of EIT Global, alongside Dr David Agus. Under his direction, EIT Oxford will drive scientific and technological innovation in EIT’s four key areas: medical science and healthcare, food security and sustainable agriculture, clean energy and... Read more

The Daubeny Project

Imaginative design, inspiring spaces.

450,000 sq ft of
premium lab space
completing 2026

Discover More